Ellisons’ Corporate and Commercial team is delighted to have advised the shareholders of Quadrachem Laboratories Limited in connection with the sale of the company. From its headquarters in East Sussex Quadrachem provides rapid analytical testing products for laboratory scientists throughout the UK.

This transaction was structured by way of management buy-out and Ellisons’ advised the company’s shareholders, the outgoing management team. Financial advice was provided throughout the deal by RSM UK.

The team at Ellisons was led by Corporate & Commercial Partner Paul Forsyth with assistance being provided by Abigail Williamson, Solicitor. Paul Forsyth commented: ‘It was a privilege to assist the majority shareholders with the sale of their company, which they have been involved with for many years. This was a complex transaction with the involvement of an EMI Scheme and security provisions to protect the selling shareholders.  

A sale by way of management team buy-in is one of the many types of structure a deal can take. The team at Ellisons have extensive M&A experience advising on all types of transactions, that includes private equity backed, employee ownership trusts or, as in this case, management buy in/buy out.  We are always happy to meet with potential clients to explain the benefits and drawbacks of each type of transaction structure as part of preliminary deal advice.

Fiona Watts, Managing Director at Quadrachem, commented: ‘Paul and Abigail were very professional, knowledgeable and supportive throughout this not so straightforward process and were there for us every step of the way to ensure a successful outcome for all stakeholders.  After starting the company over 40 years ago, it was important to us to leave a legacy and to ensure a smooth transition for our loyal staff, customers and suppliers. Thank you.’